Teladoc Health (NYSE: TDOC) reported its second-quarter results after the market closed on Tuesday. With such a steep sell-off, you might think that Teladoc has big problems. Here are three things investors might have missed with Teladoc's Q2 update.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting